Beacon Pointe Advisors’s OS Therapies Inc OSTX Stock Holding History

Beacon Pointe Advisors’s Portfolio OSTX Stock Details OSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119K	Hold	62,507	–	–	﹤0.01%	1860
2026 Q1	$88.1K	Buy	+62,507	New	+$88.7K	﹤0.01%	1792

Other funds holding OSTX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Beacon Pointe Advisors's OSTX Position: Q2 2026 in Review

Beacon Pointe Advisors held its OS Therapies Inc (OSTX) position steady in Q2 2026 at 62,507 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

Beacon Pointe Advisors first reported a position in OSTX in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

Beacon Pointe Advisors held 62,507 shares of OS Therapies Inc worth $119K as of Q2 2026.
Beacon Pointe Advisors left its OS Therapies Inc share count unchanged in Q2 2026.
OS Therapies Inc made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1860 holding.
Beacon Pointe Advisors first reported a position in OS Therapies Inc in Q1 2026 and has held it in 2 quarters since.
29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.